Regulation of bcl-2 gene family members in human endometrium by antiprogestin administration in vivo

Citation
Hod. Critchley et al., Regulation of bcl-2 gene family members in human endometrium by antiprogestin administration in vivo, J REPR FERT, 115(2), 1999, pp. 389-395
Citations number
21
Categorie Soggetti
da verificare
Journal title
JOURNAL OF REPRODUCTION AND FERTILITY
ISSN journal
00224251 → ACNP
Volume
115
Issue
2
Year of publication
1999
Pages
389 - 395
Database
ISI
SICI code
0022-4251(199903)115:2<389:ROBGFM>2.0.ZU;2-0
Abstract
It is likely that the changes which occur in the endometrium throughout the menstrual cycle involve apoptosis, and that expression of associated genes , such as the bcl-2 family, are regulated by sex steroids. The aim of this study was to investigate the presence of bcl-2, Bar and oestrogen receptor proteins in secretory endometrium collected from ten patients with normal o vulatory cycles 4 or 6 days after the LH surge, and on the same days in a s ubsequent cycle in which the formation of secretory changes was inhibited b y the administration of the antiprogestin mifepristone (RU486) 2 days after the onset of the LH surge. Since some stromal cells display positive immun oreactivity, leucocyte subpopulations of macrophages (CD68-positive) and la rge granular lymphocytes (CD56-positive) were identified in serial sections . After administration of mifepristone on day 2 after the LH surge, a signi ficant increase in bcl2 immunoreactivity was observed in glandular and surf ace epithelium. A positive correlation (0.874) with nuclear oestrogen recep tor immunoreactivity in endometrial glands was demonstrated. Subsets of str omal cells, identified as CD68-positive macrophages and CD56-positive large granular lymphocytes displayed positive immunoreactivity for the bcl-2 epi tope, which was unaffected by mifepristone administration. Bar immunostaini ng was similar in control and antiprogestin-treated endometrium. These data indicate that antiprogestin administration inhibits progesterone downregul ation of steroid receptors in endometrial glands, resulting in persistence of a proliferative endometrium and accompanying bcl-2 secretion.